Tumor incidence in related hematopoietic stem cell donors

Bone Marrow Transplantation

Volumn 46, Issue 9, 2011, Pages 1240-1244

  Jeger, A ^a   Favre, G ^a   Lutz, J M ^b   Stern, M ^a   Usel, M ^b   Rovo, A ^a   Rischewski, J ^a   Tichelli, A ^a   Gratwohl, A ^a   Halter, J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

donors; hematopoietic stem cell transplantation; tumor incidence

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE TUMOR; BREAST TUMOR; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CHRONIC LYMPHATIC LEUKEMIA; COLON TUMOR; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IATROGENIC DISEASE; LIVING DONOR; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MELANOMA; NERVE TUMOR; OVARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TESTIS TUMOR; TUMOR LOCALIZATION; UTERINE CERVIX TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COHORT STUDIES; FEMALE; GERMANY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; SWITZERLAND; TISSUE DONORS; YOUNG ADULT;

EID: 80052503305     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.291     Document Type: Article

References (18)

1. Bach FH, Albertin RJ, Joo P, Anderson JL, Bortin MM. Bone-marrow transplantation in a patient with Wiskott-Aldrich syndrome. Lancet 1968; 2: 1364-1366.
2. Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J, Frauendorfer K et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009; 43: 229-275.
3. Tichelli A, Bucher C, Rovo A, Stussi G, Stern M, Paulussen M et al. Premature cardiovascular disease after allogeneic stem cell transplantation. Blood 2007; 110: 3463-3471. (Pubitemid 350106343)
4. Socié G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A et al. Nonmalignant late effects after allogeneic transplantation. Blood 2003; 101: 3373-3385. (Pubitemid 36857917)
5. Rizzo JD, Curtis RE, Socié G, Sobocinski KA, Gilbert E, Landgren O et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 2009; 113: 1175-1183.
6. Halter J, Kodera Y, Ispizua AU, Greinix HT, Schmitz N, Favre G et al. Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica 2009; 94: 94-101.
7. Favre G, Beksaç M, Bacigalupo A, Ruutu T, Nagler A, Gluckman E et al. Differences between graft product and donor side effects following bone marrow or stem cell donation. Bone Marrow Transplant 2003; 32: 873-880. (Pubitemid 37369264)
8. Niederwieser DW, Appelbaum FR, Gastl G, Gersdorf E, Meister B, Geissler D et al. Inadvertent transmission of a donor's acute myeloid leukemia in bone-marrow transplantation for chronic myelocytic leukemia. N Engl J Med 1990; 322: 1794-1796. (Pubitemid 20194659)
9. Hasenclever D, Sextro M. Safety of AlloPBPCT donors: biometrical considerations on monitoring long term risks. Bone Marrow Transplant 1996; 17: 28-30.
10. Anderlini P, Champlin RE. Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges. Blood 2008; 111: 1767-1772. (Pubitemid 351451480)
11. Goldin LR, Caporaso NE. Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours. Br J Haematol 2007; 139: 774-779. (Pubitemid 350119794)
12. Pang D, Alston RD, Eden TOB, Birch JM. Cancer risks among relatives of children with Hodgkin and non-Hodgkin lymphoma. Int J Cancer 2008; 123: 1407-1410.
13. Fisch T, Pury P, Probst N, Bordoni A, Bouchardy C, Frick H et al. Variation in survival after diagnosis of breast cancer in Switzerland. Ann Oncol 2005; 16: 1882-1888. (Pubitemid 41724276)
14. Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008; 9: 730-756.
15. De la Rubia J, De Arriba F, Arbona C, Pascual MJ, Zamora C, Insunza A et al. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry. Haematologica 2008; 93: 735-740. (Pubitemid 351669314)
16. Friedman DL, Rovo A, Leisenring W, Locasciulli A, Flowers MED, Tichelli A et al. Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party. Blood 2008; 111: 939-944.
17. Bhatia S, Louie AD, Bhatia R, O'Donnell MR, Fung H, Kashyap A et al. Solid cancers after bone marrow transplantation. J Clin Oncol 2001; 19: 464-471. (Pubitemid 32112860)
18. Bennett CL, Evens AM, Andritsos LA, Balasubramanian L, Mai M, Fisher MJ et al. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol 2006; 135: 642-650. (Pubitemid 44674074)